Organization

University of Texas at Austin

11 clinical trials

4 abstracts

Abstract
Feasibility of using the handheld MasSpec pen technology for intraoperative identification of ovarian cancer during tumor reductive surgery.
Org: Department of Gynecologic Oncology & Reproductive Medicine, University of Texas at Austin,
Clinical trial
Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation
Status: Completed, Estimated PCD: 2023-06-14
Clinical trial
Misoprostol Dosing in BMI Greater Than 30: A Randomized Controlled Trial
Status: Completed, Estimated PCD: 2023-07-14
Clinical trial
Dietary Acid Reduction and Progression of Chronic Kidney Disease
Status: Completed, Estimated PCD: 2006-11-15
Abstract
Mutation-site localized non-B DNA burden and survival heterogeneity in early-stage pancreatic cancer.
Org: Livestrong Cancer Institutes, University of Texas at Austin, Austin, TX, The University of Texas at Austin Dell Medical School,
Abstract
Correlation between biomarkers and treatment outcomes in diverse cancers: A meta-analysis of phase I and II immunotherapy clinical trials.
Org: St Lukes Clinic, University of Texas MD Anderson Cancer Center, University of Texas at Austin, Medical College of Wisconsin, WIN Consortium,